Champions Oncology, Inc.CSBRNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank87
3Y CAGR-1.7%
5Y CAGR+7.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.7%/yr
vs +23.1%/yr prior
5Y CAGR
+7.3%/yr
Recent deceleration
Acceleration
-24.8pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $27.36M | +24.0% |
| 2025 | $22.07M | -20.3% |
| 2024 | $27.68M | -3.9% |
| 2023 | $28.79M | +15.7% |
| 2022 | $24.87M | +29.3% |
| 2021 | $19.23M | +15.1% |
| 2020 | $16.71M | +33.3% |
| 2019 | $12.53M | +13.5% |
| 2018 | $11.04M | -11.8% |
| 2017 | $12.52M | - |